GMP
Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur
Intravacc
PR-M03-22-09Mar 22, 2022
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06Mar 15, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22Jan 31, 2022
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
PR-M06-21-024Jun 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01Jun 04, 2021
Vaccine
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Vaxxas
PR-M06-21-006Jun 04, 2021
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
Samsung Biologics
PR-M05-21-016May 25, 2021
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-03May 17, 2021
Partnership
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
DNA Script
PR-M04-21-029Apr 29, 2021
Immunity
The Link Between COVID-19 and Immunity
Dr. Andrew Myers
PTV-04-21-CL-003Apr 28, 2021
Manufacturing
Sanofi to Invest in Vaccine Production Site in Singapore
Sanofi
PR-M04-21-011Apr 13, 2021
Vaccine
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Valneva SE
PR-M04-21-006Apr 08, 2021
COVID-19 Vaccine
UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation
UBC
PR-M11-20-046Mar 09, 2021
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Rentschler Biopharma SE
PAP-Q4-20-CL-028Dec 09, 2020
COVID-19 Impacts
Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
Pharma's Almanac
PAP-Q4-20-NI-006Dec 09, 2020
COVID-19 Vaccine
Russia's Sputnik V COVID-19 Vaccine Is 91% Effective
The Russian Direct Investment Fund (RDIF)
PR-M11-20-023-1178Nov 24, 2020
COVID-19 Vaccine
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna
PR-M11-20-013Nov 16, 2020
Cancer Vaccine
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
Moderna
PR-M11-20-009Nov 11, 2020
Fast Track
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax
PR-M11-20-008Nov 10, 2020
COVID-19 Vaccine
Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine
GSK
PR-M10-20-18Oct 28, 2020